Receptors in Breast Cancer

Marc E. Lippman, Joseph C. Allegra

Research output: Contribution to journalReview articlepeer-review

76 Scopus citations

Abstract

Estrogen Receptor and Endocrine Therapy of Breast Cancer SINCE the pioneering work of George Beatson,1 who induced tumor regressions in patients with advanced breast cancer by oophorectomy, it has been appreciated that some human breast cancers will respond to endocrine manipulations. It is established that patients who respond to such endocrine therapies have not only palliation of their disease but increased survival as well. Unfortunately, no more than about a third of unselected patients with metastatic breast cancer will have objective tumor regressions after initiation of endocrine therapy. Thus, if endocrine therapies are applied nonselectively, the majority of patients will.

Original languageEnglish (US)
Pages (from-to)930-933
Number of pages4
JournalNew England Journal of Medicine
Volume299
Issue number17
DOIs
StatePublished - Oct 26 1978

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Receptors in Breast Cancer'. Together they form a unique fingerprint.

Cite this